RM
RMD
RESMED INC
$194.78
+1.24%
$28.3B
No data for this timeframe.
Vol
Market Cap$28.3B
Cap SizeLarge Cap
Analyst ConsensusBuy (60%)
Inst. Holders50 funds
Inst. Value$14.2B
Inst. Activity30 buys / 20 sells
Insider Activity0B / 12S
Insider Net $-$8.0M
Reddit Sentiment43° Neutral
SEC Reports7
Press Releases1
Congressional1 trades
Exchange OTC·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0000943819·Prev Close $192.39
Recent Activity
Jun 12, 2026
short_volume
Short Volume: RMD — 77.1% short (0.4M / 0.5M)
Short: 396,079 | Exempt: 6,354 | TRF Vol: 513,878 | Short Ratio: 77.1% | Off-exchange volume (dark p
Jun 8, 2026
Insider
Farrell Michael J. acquired via exercise 4,991 shares
Chairman and CEO @ $146.34 ($730.4K)
Jun 8, 2026
Insider
Farrell Michael J. sold 4,991 shares
Chairman and CEO @ $193.96 ($968.1K)
Jun 1, 2026
Press
Resmed completed its acquisition of Noctrix Health, adding an FDA-cleared non-pharmacologic treatment for Restless Legs
Impact 5/10
Jun 1, 2026
Insider
Rider Michael J surrendered for taxes 268.742 shares
Global General Counsel @ $190.57 ($51.2K)
May 19, 2026
SEC
Resmed reports fiscal Q3 2026 EPS of $2.86, a 1.4% miss vs consensus of $2.90. The miss breaks a streak of four consecut
PRESS-RELEASE — Impact 5/10
Apr 9, 2026
SEC
ResMed insiders sold $1.8M in shares over a 7-day period, led by CEO Michael Farrell's $1.13M open-market sale following
CLUSTER — Impact 3/10
Apr 3, 2026
SEC
Two corporate insiders at ResMed sold shares in a coordinated 7-day window, including CFO Brett Sandercock selling $224K
CLUSTER — Impact 5/10
Price Targets
$270.60
+38.9% upside
Strong Buy
Current $194.78
Low $180.00
Median $286.00
High $340.00
15 analysts
$180.00
$340.00
Analyst Ratings
4Strong Buy
11Buy
8Hold
1Sell
1Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 1, 2026 | RBC Capital | MAINTAIN | Outperform → Outperform |
| May 1, 2026 | Wells Fargo | MAINTAIN | Equal-Weight → Equal-Weight |
| Apr 27, 2026 | Keybanc | MAINTAIN | Overweight → Overweight |
| Apr 9, 2026 | Citigroup | MAINTAIN | Buy → Buy |
| Feb 2, 2026 | Citigroup | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $2.88 ▼ -0.8% | $2.81 — $2.92 | 13% YoY | 4 |
| Next Q | $2.86 | $2.82 — $2.90 | 12% YoY | 3 |
| Current FY | $11.12 | $10.98 — $11.20 | 16% YoY | 8 |
| Next FY | $12.14 | $11.97 — $12.53 | 9% YoY | 8 |
Latest Reports
BULLISH
Press
5/10
Resmed completed its acquisition of Noctrix Health, adding an FDA-cleared non-pharmacologic treatment for Restless Legs
Jun 1, 2026
BEARISH
PRESS-RELEASE
5/10
Resmed reports fiscal Q3 2026 EPS of $2.86, a 1.4% miss vs consensus of $2.90. The miss breaks a streak of four consecut
May 19, 2026
NEUTRAL
CLUSTER
3/10
ResMed insiders sold $1.8M in shares over a 7-day period, led by CEO Michael Farrell's $1.13M open-market sale following
Apr 9, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| Erste Asset Management GmbH | — | — |
| BlackRock, Inc. | $2.7B | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.1B | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.8B | — |
| STATE STREET CORP | $1.5B | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 8, 2026 | Farrell Michael | M | $730.4K |
| Jun 8, 2026 | Farrell Michael | SELL | $968.1K |
| Jun 1, 2026 | Rider Michael | F | $51.2K |
| May 7, 2026 | Farrell Michael | M | $730.4K |
| May 7, 2026 | Farrell Michael | SELL | $1.0M |
Reddit Sentiment
43°
Neutral
Bearish
Neutral
Bullish
Congressional Trades
1 members: 1 buys, 0 sells
| Member | Party | Type | Amount |
|---|---|---|---|
| Ro Khanna | D | BUY | $1,001 - $15,000 |
50 institutional holders with $14.2B total value (63,286,415 shares) as of 2026-Q1. Top holders: Erste, BlackRock,, VANGUARD. Net buying activity: 30 institutions added/increased vs 20 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | Erste Asset Management GmbH | — | $0.00 | 0.0% | — |
| 2 | BlackRock, Inc. | 12,094,023 | $2.7B | 19.1% | — |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 9,466,416 | $2.1B | 15.0% | — |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 7,863,922 | $1.8B | 12.4% | — |
| 5 | STATE STREET CORP | 6,643,168 | $1.5B | 10.5% | — |
| 6 | MORGAN STANLEY | 2,686,821 | $603.1M | 4.2% | — |
| 7 | Invesco Ltd. | 1,956,614 | $439.2M | 3.1% | — |
| 8 | FIRST TRUST ADVISORS LP | 1,537,825 | $345.2M | 2.4% | — |
| 9 | DEUTSCHE BANK AG\ | 1,422,865 | $319.4M | 2.2% | — |
| 10 | Swedbank AB | 1,350,234 | $303.1M | 2.1% | — |
| 11 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,135,299 | $254.9M | 1.8% | — |
| 12 | Amundi | 1,062,184 | $238.4M | 1.7% | DOUBLED +123.9% |
| 13 | NORDEA INVESTMENT MANAGEMENT AB | 1,033,381 | $227.0M | 1.6% | — |
| 14 | GOLDMAN SACHS GROUP INC | 1,004,205 | $225.4M | 1.6% | — |
| 15 | DIMENSIONAL FUND ADVISORS LP | 1,004,218 | $225.4M | 1.6% | — |
| 16 | Legal & General Group Plc | 990,361 | $222.3M | 1.6% | — |
| 17 | BANK OF AMERICA CORP /DE/ | 928,430 | $208.4M | 1.5% | — |
| 18 | VANGUARD FIDUCIARY TRUST CO | 825,076 | $185.2M | 1.3% | — |
| 19 | CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 538,031 | $120.8M | 0.9% | — |
| 20 | CAPTRUST FINANCIAL ADVISORS | 487,861 | $109.5M | 0.8% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| Amundi | DOUBLED | 474,312 | 1,062,184 | +123.9% | $238.4M | 2026-Q1 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | 273,609 | 450,250 | +64.6% | $101.1M | 2026-Q1 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | DOUBLED | 126,700 | 436,314 | +244.4% | $97.9M | 2026-Q1 |
| MARSHALL WACE, LLP | NEW | — | 381,296 | — | $85.6M | 2026-Q1 |
| FIL Ltd | TRIM | 448,132 | 300,025 | -33.0% | $67.3M | 2026-Q1 |
| PINEBRIDGE INVESTMENTS LLC | ADD | 142,856 | 184,320 | +29.0% | $41.4M | 2026-Q1 |
| VICTORY CAPITAL MANAGEMENT INC | TRIM | 279,939 | 179,288 | -36.0% | $40.2M | 2026-Q1 |
| CANADA PENSION PLAN INVESTMENT BOARD | DOUBLED | 4,546 | 159,221 | +3402.4% | $35.7M | 2026-Q1 |
| FRANKLIN RESOURCES INC | TRIM | 215,348 | 152,616 | -29.1% | $34.3M | 2026-Q1 |
| NATIXIS | NEW | — | 112,178 | — | $25.2M | 2026-Q1 |
| Trexquant Investment LP | DOUBLED | 37,854 | 107,292 | +183.4% | $24.1M | 2026-Q1 |
| MACQUARIE GROUP LTD | TRIM | 130,342 | 89,565 | -31.3% | $20.1M | 2026-Q1 |
| SEI INVESTMENTS CO | TRIM | 128,614 | 85,055 | -33.9% | $19.1M | 2026-Q1 |
| NATIONAL BANK OF CANADA /FI/ | TRIM | 96,663 | 62,905 | -34.9% | $14.1M | 2026-Q1 |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | ADD | 33,488 | 58,848 | +75.7% | $13.2M | 2026-Q1 |
| CREDIT AGRICOLE S A | TRIM | 77,898 | 57,126 | -26.7% | $12.8M | 2026-Q1 |
| Assenagon Asset Management S.A. | TRIM | 80,669 | 56,570 | -29.9% | $12.7M | 2026-Q1 |
| Tredje AP-fonden | DOUBLED | 14,701 | 55,932 | +280.5% | $12.6M | 2026-Q1 |
| Korea Investment CORP | TRIM | 85,403 | 50,803 | -40.5% | $11.4M | 2026-Q1 |
| Mariner, LLC | TRIM | 63,924 | 39,250 | -38.6% | $8.8M | 2026-Q1 |
| NOMURA HOLDINGS INC | ADD | 25,240 | 36,993 | +46.6% | $8.3M | 2026-Q1 |
| TD Waterhouse Canada Inc. | DOUBLED | 1,788 | 35,498 | +1885.3% | $7.9M | 2026-Q1 |
| FIFTH THIRD BANCORP | DOUBLED | 9,791 | 32,985 | +236.9% | $7.4M | 2026-Q1 |
| Mirae Asset Global Investments Co., Ltd. | ADD | 23,810 | 31,589 | +32.7% | $7.1M | 2026-Q1 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | ADD | 16,400 | 23,489 | +43.2% | $5.3M | 2026-Q1 |
4 unique insiders with 18 transactions. Net insider value: -$8.0M ($0.00 bought, $8.0M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | Farrell Michael J. | Chairman and CEO | EXERCISE | 4,991 | $146.34 | $730.4K |
| Jun 8, 2026 | Farrell Michael J. | Chairman and CEO | SELL | 4,991 | $193.96 | $968.1K |
| Jun 1, 2026 | Rider Michael J | Global General Counsel | TAX W/H | 268.742 | $190.57 | $51.2K |
| May 7, 2026 | Farrell Michael J. | Chairman and CEO | EXERCISE | 4,991 | $146.34 | $730.4K |
| May 7, 2026 | Farrell Michael J. | Chairman and CEO | SELL | 4,991 | $207.82 | $1.0M |
| Apr 7, 2026 | Farrell Michael J. | Chairman and CEO | EXERCISE | 4,991 | $146.34 | $730.4K |
| Apr 7, 2026 | Farrell Michael J. | Chairman and CEO | SELL | 4,991 | $225.50 | $1.1M |
| Apr 1, 2026 | FARRELL PETER C | Director | SELL | 2,000 | $225.00 | $450.0K |
| Apr 1, 2026 | Sandercock Brett | Chief Financial Officer | SELL | 1,000 | $224.31 | $224.3K |
| Mar 9, 2026 | Farrell Michael J. | Chairman and CEO | EXERCISE | 4,991 | $146.34 | $730.4K |
| Mar 9, 2026 | Farrell Michael J. | Chairman and CEO | SELL | 4,991 | $251.03 | $1.3M |
| Mar 4, 2026 | FARRELL PETER C | Director | SELL | 2,000 | $260.22 | $520.4K |
| Mar 2, 2026 | Sandercock Brett | Chief Financial Officer | SELL | 1,000 | $254.30 | $254.3K |
| Feb 9, 2026 | Farrell Michael J. | Chairman and CEO | SELL | 4,991 | $273.78 | $1.4M |
| Feb 9, 2026 | Farrell Michael J. | Chairman and CEO | EXERCISE | 4,991 | $146.34 | $730.4K |
| Feb 4, 2026 | Rider Michael J | Global General Counsel | SELL | 50 | $260.00 | $13.0K |
| Feb 4, 2026 | FARRELL PETER C | Director | SELL | 2,000 | $251.31 | $502.6K |
| Feb 2, 2026 | Sandercock Brett | Chief Financial Officer | SELL | 1,000 | $257.03 | $257.0K |
7 SEC filing reports analyzed. Sentiment: 1 bullish, 2 bearish, 0 mixed, 4 neutral. Avg impact: 4.1/10.
BEARISH
PRESS-RELEASE
5/10
Resmed reports fiscal Q3 2026 EPS of $2.86, a 1.4% miss vs consensus of $2.90. The miss breaks a str
May 19, 2026
NEUTRAL
CLUSTER
3/10
ResMed insiders sold $1.8M in shares over a 7-day period, led by CEO Michael Farrell's $1.13M open-m
Apr 9, 2026
BEARISH
CLUSTER
5/10
Two corporate insiders at ResMed sold shares in a coordinated 7-day window, including CFO Brett Sand
Apr 3, 2026
NEUTRAL
PRESS-RELEASE
2/10
ResMed issued a press release announcing the upcoming date for its Q3 FY2026 earnings release on Apr
Apr 1, 2026
NEUTRAL
CLUSTER
4/10
ResMed CEO Michael J. Farrell exercised stock options and sold 4,991 shares in the open market for a
Mar 11, 2026
NEUTRAL
CLUSTER
3/10
Two ResMed insiders, including CFO Brett Sandercock, sold shares in the past week, totaling $774,740
Mar 5, 2026
BULLISH
INST-CLUSTER
7/10
Three major institutions — Morgan Stanley, Norges Bank, and RenTech — collectively added $369.9M in
Feb 28, 2026
Current analyst consensus: Buy (60% buy). Based on 25 analysts: 4 strong buy, 11 buy, 8 hold, 1 sell, 1 strong sell.
Analyst Price Targets
$270.60 mean target
+38.9% upside
Strong Buy (2.05)
$180.00 Low
$340.00 High
| Metric | Value |
|---|---|
| Current Price | $194.78 |
| Target Low | $180.00 |
| Target Mean | $270.60 |
| Target Median | $286.00 |
| Target High | $340.00 |
| # Analysts | 15 |
| Recommendation | Strong Buy (2.05) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$2.88 | $2.81 | $2.92 | 12.9% | -0.8% | 9↑ 4↓ | $1.5B | 8.8% | 4 |
| Next Q 2026-09-30 |
$2.86 | $2.82 | $2.90 | 12.2% | -0.3% | 3↑ 4↓ | $1.4B | 8.3% | 3 |
| Current FY 2026-06-30 |
$11.12 | $10.98 | $11.20 | 16.4% | -0.2% | 16↑ 3↓ | $5.7B | 9.9% | 8 |
| Next FY 2027-06-30 |
$12.14 | $11.97 | $12.53 | 9.2% | -0.5% | 11↑ 8↓ | $6.1B | 8.0% | 8 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $2.880 | |
| 7d ago | $2.903 | -0.023 |
| 30d ago | $2.903 | -0.024 |
| 60d ago | $2.889 | -0.010 |
| 90d ago | $2.893 | -0.013 |
7 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 1, 2026 | RBC Capital | MAINTAIN | Outperform | Outperform |
| May 1, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | Equal-Weight |
| Apr 27, 2026 | Keybanc | MAINTAIN | Overweight | Overweight |
| Apr 9, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| Feb 2, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| Jan 30, 2026 | RBC Capital | MAINTAIN | Outperform | Outperform |
| Jan 30, 2026 | Piper Sandler | MAINTAIN | Neutral | Neutral |
| Jan 30, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | Equal-Weight |
| Jan 30, 2026 | Stifel | MAINTAIN | Hold | Hold |
| Dec 18, 2025 | Stifel | MAINTAIN | Hold | Hold |
| Dec 16, 2025 | Baird | DOWNGRADE | Outperform | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 11 | 8 | 1 | 1 | 60% | |
| May 1, 2026 | 4 | 12 | 9 | 0 | 1 | 62% | |
| Apr 1, 2026 | 4 | 11 | 9 | 0 | 1 | 60% | |
| Mar 1, 2026 | 4 | 12 | 8 | 0 | 1 | 64% | |
| Feb 1, 2026 | 4 | 12 | 8 | 0 | 1 | 64% | |
| Jan 1, 2026 | 4 | 12 | 8 | 0 | 1 | 64% |
Strong BuyBuyHoldSellStrong Sell
1 members of Congress traded this stock: 1 buys, 0 sells.
Congressional Trades
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Ro Khanna | D | HOUSE | BUY | $1,001 - $15,000 | Resmed Inc | May 13, 2026 (31d) |
43°
Neutral
Bearish
Neutral
Bullish
3 mentions
0 bullish
1 bearish
3 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Jun 3, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Jun 3, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Feb 22, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
Recent Reddit Threads
Wondering the best time to take RMD?
▲ 1
💬 0
⚡ 0.5
Retired and now I have to worry about RMD Distribution
▲ 1
💬 1
⚡ 0.0
Jun 12, 2026
short_volume
Short Volume: RMD — 77.1% short (0.4M / 0.5M)
Short: 396,079 | Exempt: 6,354 | TRF Vol: 513,878 | Short Ratio: 77.1% | Off-exchange volume (dark pool + OTC)
Jun 5, 2026
short_volume
Short Volume: RMD — 80.6% short (0.5M / 0.7M)
Short: 543,815 | Exempt: 968 | TRF Vol: 674,957 | Short Ratio: 80.6% | Off-exchange volume (dark pool + OTC)
Jun 4, 2026
short_volume
Short Volume: RMD — 77.8% short (0.5M / 0.6M)
Short: 502,944 | Exempt: 59 | TRF Vol: 646,074 | Short Ratio: 77.8% | Off-exchange volume (dark pool + OTC)
Jun 3, 2026
short_volume
Short Volume: RMD — 73.0% short (0.5M / 0.7M)
Short: 502,405 | Exempt: 792 | TRF Vol: 688,596 | Short Ratio: 73.0% | Off-exchange volume (dark pool + OTC)
Jun 2, 2026
short_volume
Short Volume: RMD — 71.0% short (0.5M / 0.7M)
Short: 500,017 | Exempt: 41 | TRF Vol: 704,324 | Short Ratio: 71.0% | Off-exchange volume (dark pool + OTC)
Jun 1, 2026
m_and_a
Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio
Acquisition adds Nidra® Tonic Motor Activation (TOMAC) Therapy, an FDA De Novo classified, nonpharmacologic treatment designed to address moderate-to-
Jun 1, 2026
short_volume
Short Volume: RMD — 74.3% short (0.8M / 1.1M)
Short: 814,636 | Exempt: 3,869 | TRF Vol: 1,096,707 | Short Ratio: 74.3% | Off-exchange volume (dark pool + OTC)
May 29, 2026
short_volume
Short Volume: RMD — 89.3% short (0.9M / 1.0M)
Short: 937,135 | Exempt: 33 | TRF Vol: 1,048,982 | Short Ratio: 89.3% | Off-exchange volume (dark pool + OTC)
May 28, 2026
short_volume
Short Volume: RMD — 82.1% short (0.5M / 0.6M)
Short: 463,326 | Exempt: 9 | TRF Vol: 564,496 | Short Ratio: 82.1% | Off-exchange volume (dark pool + OTC)
May 26, 2026
short_volume
Short Volume: RMD — 65.3% short (0.3M / 0.5M)
Short: 340,590 | Exempt: 895 | TRF Vol: 521,861 | Short Ratio: 65.3% | Off-exchange volume (dark pool + OTC)
May 19, 2026
earnings
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
<p align="left">SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive
May 18, 2026
dark_pool
Dark Pool: RMD — 2.0M shares, 56,279 trades
Week starting 2026-05-18. Total ATS volume: 2,029,381 shares across 56,279 trades.
May 13, 2026
short_interest
FTD: RMD — 9,948 shares ($2.0M) failed to deliver
Settlement: 20260513, Price: $203.79, FTD Value: $2,027,302.92, RESMED INC
May 12, 2026
short_volume
Short Volume: RMD — 57.9% short (0.3M / 0.6M)
Short: 325,290 | Exempt: 1,321 | TRF Vol: 561,430 | Short Ratio: 57.9% | Off-exchange volume (dark pool + OTC)
May 11, 2026
short_volume
Short Volume: RMD — 57.0% short (0.4M / 0.8M)
Short: 447,707 | Exempt: 0 | TRF Vol: 785,258 | Short Ratio: 57.0% | Off-exchange volume (dark pool + OTC)